IntRoductIon
Hypokalemia defined as plasma potassium level <3.5 mmol/L is one of the most common electrolyte disturbances encountered in clinical practice. Mild hypokalemia (plasma potassium 3.0-3.5 mmol/L) is usually asymptomatic; however, severe hypokalemia (plasma potassium <2.5 mmol/L) can be associated with acute flaccid paralysis of limbs along with involvement of respiratory or cardiac system. Among the many causes of hypokalemia, distal renal tubular acidosis (RTA) due to Sjögren syndrome is an important entity. The following case report illustrates this scenario.
case RePoRt
• Fifty two year old female presented with weakness of both upper and lower limbs of 1-day duration. Weakness was gradual in onset but slowly progressed over time resulting in difficulty in getting up from bed. The patient did not have any history of fever, trauma, chronic diarrhea, increase urine output, palpitations, tremors, excessive sweating, and chronic drug use. There is also no history of double vision, dropping of eyelid, difficulty in speech or swallowing or regurgitation, sensory complaints, bowel and bladder involvement, muscle cramps, joint pain, or diurnal variation of weakness. However, she did give a history of similar episodes of weakness of lower limbs 3 months back where she was treated in a local hospital with complete recovery, the details of which were not available. There is also no history of diabetes, 
dIscussIon
The patient presented with weakness of all four limbs without fever, sensory, bladder and bowel involvement. [1] The differentials that were considered included (1) periodic paralysis (2) neuromuscular disorders-myasthenia gravis, Lambert-Eaton syndrome (3) Myelopathy-compressive myelopathy, transverse myelitis (4) miscellenous causes such as porphyria, HIV, vasculitic neuropathy, drugs/toxin-alcohol, and heavy metals such as arsenic and thallium. Neuromuscular disorders such as myasthenia gravis presents with easy fatigability, extraocular muscle involvement, and variable weakness of voluntary muscle which is absent in this patient. Myelopathy ruled out as the patient did not sensory, bladder, and bowel involvement along with absent spasticity, extensor plantar response. Likewise miscellaneous causes were ruled through history, blood investigation.
Periodic paralysis are a group of disorders characterized by episodes of flaccid paralysis occurring at irregular interval with complete recovery in between attack. Most of the cases are as follows: (1) hereditary with autosomal dominance inheritance, (2) associated with alteration of sodium and potassium levels, (3) the various forms being hypokalemic, hyperkalemic, thyrotoxic, and paramyotonia congenital and (4) symptoms are most evident during childhood and adolescence and are triggered by large carbohydrate meal, vigorous exercise, and viral illness.
The patient in our case had severe hypokalemia with acute flaccid paralysis of all four limbs along with respiratory muscle. However, the age of onset being above 50 years, the likelihood of being an inherited condition becomes a remote possibility. Evaluation and careful investigation of hypokalemia brought to light condition of metabolic acidosis with normal anion gap with urine pH of >5 and positive urinary anion gap which in turn revealed distal RTA Type 1. When the causes of distal RTA were investigated, high-positive Sjögren antibodies were found. Further, examination of eyes, mouth revealed severe dryness with positive Schirmer's test, and lip biopsy showed chronic lymphocytic sialadenitis. [2] • Unstimulated whole salivary flow (≤1.5 mL in 15 min) • Abnormal parotid sialography [3] • Abnormal salivary scintigraphy [4] 6. Autoantibodies (at least one)
• Anti-SSA (Ro) or Anti-SSB (La).
For a primary Sjögren's diagnosis: a. Any four of the six criteria must include either item IV (histopathology) or VI (autoantibodies) b. Any three of the four objective criteria (III, IV, V, and VI).
For a secondary Sjögren's diagnosis: • In patients with another well-defined major connective tissue disease, the presence of one symptom (I or II) plus two of the three objective criteria (III, IV, and V) is indicative of secondary SS.
Exclusion criteria:
• Past head and neck radiation treatment • Hepatitis C infection • Acquired immunodeficiency syndrome • Preexisting lymphoma • Sarcoidosis • Graft versus host disease • Current use of anticholinergic drugs [3] Sjögren syndrome is chronic systemic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands. The disease can present as alone (primary Sjögren syndrome) or associated with other autoimmune conditions such as SLE, rheumatoid arthritis, and scleroderma (secondary Sjögren syndrome). The prevalence of primary Sjögren's syndrome is ~0.5%-1% and middle-aged women (female-to-male ratio is 9:1) are primarily affected. [4] Most patients presents with sicca symptoms such as xerophthalmia (dry eyes), xerostomia (dry mouth), and parotid gland enlargement. In addition, various extraglandular features may develop. This includes arthralgia, arthritis, vasculitis, lymphoma, renal involvement, and Raynauds phenomenon. [5] Renal involvement includes proximal and distal tubular acidosis, tubular proteinuria, and nephrogenic diabetes insipidus. [6] The mechanism of hypokalemia in Sjögren syndrome is because of distal RTA brought about by chronic interstitial nephritis which in turn leads to decrease tubular sodium delivery, defective H-KATPase, secondary hyperaldosteronism, and bicarbonaturia [ Figure 1 ].
conclusIon
When a patient presents with hypokalemic paralysis, the notion of labeling it to be a case of periodic paralysis may not always be a wise decision if other conditions are not ruled out. For this, a good history, clinical examination, thorough knowledge of arterial blood gas, and urine analysis are very important so that conditions such as Sjögren syndrome are not overlooked or missed.
Declaration of patient consent
The author certify that they have obtained all appropriate patient consent forms and patient and family members has agreed to publish the clinical information in the journal. The patient understand that their names and initials will not be published and due efforts are taken to conceal their identity, but anonymity cannot be guaranteed.
